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The regional distribution of ionophore A23187-induced synthesis of leukotrienes and mono-hydroxyeicosa- 
tetraenoic acids in the rat brain in vitro was investigated. Pronounced differences in leukotriene C, forrna- 
tion were observed, with the highest synthetic capacity in the hypothalamus. The formation of leukotriene 
C, was about 1Ztimes higher in the hypothalamus as compared to the cerebellum. This finding is in agree- 
ment with a possible neuroendocrine role for leukotriene C,. In contrast, the activity of leukotriene B4 syn- 
thesis was widely distributed without pronounced regional differences in the rat brain. Formation of 5, 
9-, 1 l-, 12- and 15-monohydroxyeicosatetraeonoic acid was detected in all regions. The major lipoxygenase 
product in the hypothalamus and thalamus was S-hydroxyeicosatetraenoic a id, while other monohydroxy- 
eicosatetraenoic acids predominated in the remaining regions tested. 
Hypothalamus; Lipoxygenase product; Leukotriene synthesis; (Rat brain) 
1. INTRODUCTION 
A role for leukotrienes in the central nervous 
system was first suggested by the report that these 
compounds caused excitation of cerebellar Purkin- 
je neurons [1,2]. Recently, we and other groups 
obtained results indicating the formation of cys- 
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A neuroendocrine role for LTC4 was suggested 
since LTG-immunoreactive fibers were detected in 
the median eminence [3]. The distribution of these 
fibers exhibited a pronounced overlap with 
LHRH-immunoreactive fibers. Furthermore, 
LTC4 in the picomolar range released both LH 
from dispersed rat anterior pituitary cells [ 1 l] and 
LHRH from the rat median eminence [12]. These 
results indicate a role for LTC4 in the regulation of 
LH release [13]. 
+ On leave of absence from the Ono Pharmaceutical Co. More recently, we have also reported the forma- 
Ltd., Osaka, Japan tion of LTB4 and various monohydroxyeicosate- 
teinyl-containing leukotrienes by brain tissue 
[3-61. We also reported the presence of specific 
binding sites for leukotriene (LT)G in the rat brain 
[7]. Furthermore, LTG has been reported to be ac- 
tively removed from the central nervous system 
[8]. In addition, leukotrienes may be involved in 
vasogenic cerebral edema and cerebral vasospasm 
]9,IOl. 
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traenoic acids (HETEs) in the rat brain [14]. In the 
present paper we describe the regional distribution 
of the capacity to form leukotrienes and various 
HETEs within the rat brain. 
2. MATERIAL AND METHODS 
2.1. Materials 
Synthetic LTB4, LTG, LTD4 and LTE4 were 
gifts from ON0 Pharmaceutical Co., Osaka, 
Japan. Standard samples of 5-HETE, 12-HETE 
and 15-HETE were obtained from incubations of 
human leukocytes or platelets as described [15,16). 
[5,6,8,9,11, 12,14,15-3H(N)]LTB4 (spec. act. 133 
Ci/mmol) and [14,15-3H]LTC4 (spec. act. 39.0 
Ci/mmol) were purchased from New England 
Nuclear. Ionophore A23 187 was from Calbiochem 
and Sep-Pak Cl8 cartridges from Waters 
Associates. 
2.2. Brain tissue preparation 
Ten male rats (body weight 200-300 g, patho- 
gen-free strain, Anticimex, Stockholm) were anes- 
thetized with sodium pentobarbital (40 mg/kg, 
i.p.) and perfused with ice-cold Tyrode’s solution 
(100 ml) containing sodium heparin (5 units/ml). 
The intact brains were rapidly removed and 8 dif- 
ferent regions were dissected (cortex, caudate 
nucleus, cerebellum, medulla oblongata, hypo- 
thalamus, thalamus, hippocampus and residual 
tissue) and placed in ice-cold phosphate-buffered 
saline (PBS, pH 7.4). The material from each 
region of the 10 rats was pooled separately, and the 
tissue was chopped by hand with the help of a 
razor blade at a cooled stage prior to suspension in 
ice-cold PBS (100 mg of wet wt tissue/ml of PBS). 
2.3. Incubation, purification and analysis 
The tissue was preincubated at 37°C for 10 min 
and incubated at 37’C for 30 min in the presence 
of 10 PM ionophore A23187. The reaction was 
stopped by the addition of 4 vols precooled ethanol 
( - 2O’C) containing 0.05 pCi of radioactive LTB4 
and LTG, and the mixture was filtrated, evapor- 
ated, suspended in saline and mixed with 4 vols of 
chloroform/methanol (2 : 1, v/v, Folch’s extrac- 
tion). After phase separation, the upper phase con- 
tained LTG, LTD4 and LTE4 and the lower phase 
contained LTB4 and HETEs. The extracts from 
each phase were applied to Sep-Pak Cl8 chromato- 
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graphy as reported [14]. Thereafter, the samples 
were subjected to reversed-phase high-perform- 
ance liquid chromatography (RP-HPLC) using a 
Nucleosil 120-3 column (particle size 3 pm, 3 x 100 
mm) eluted with a solvent consisting of acetoni- 
trile/methanol/water/acid (28 : 18 : 53 : 1 .O, pH 
5.6, v/v, solvent A) for separation of leukotrienes 
or methanol/water/acetic acid (73 : 27 : 0.01, v/v, 
solvent B) for separation of various HETEs at a 
flow rate of 0.4 ml/min. Identification and quan- 
titation of the products were carried out using a 
Hewlett Packard 8451A computerized diode array 
spectrofotometer as reported [ 171. The recovery of 
detected products (40-60%) was determined as 
reported [14]. 
3. RESULTS 
Fig. 1 shows typical RP-HPLC chromatograms 
obtained after incubation of the rat hypothalamus 
with lOaM ionophore A23187 at 37°C for 30 min. 
High levels of LTB4 and LTC4 were observed with 
minor levels of LTD4 (fig.la and b). Measurable 
amounts of LTE4 could not be detected. Forma- 
tion of various HETEs such as 5-HETE, 9-HETE, 
1 l-HETE, IZHETE and 15-HETE was also 
observed in the rat hypothalamus (fig. lc). 
To determine the distribution of leukotriene and 
HETE biosynthesis in various regions of the rat 
brain, the tissues were incubated with ionophore 
A23 187 under the same conditions and the samples 
were analyzed by RP-HPLC. Synthesis of LTG 
and LTB4 was observed in all regions tested (fig.2). 
The highest level of LTC4 was produced by the 
hypothalamus (234.1+ 5.6 pmol/g of tissue), and 
thalamus (127.9 -t 16.3 pmol/g of tissue), while the 
LTC4 production by the cortex (39.3 pmol/g of 
tissue) and cerebellum (19.7 + 1.3 pmol/g of tissue) 
was low (fig.2). The capacity of LTG synthesis 
was also observed in the residual tissue (89.3 + 7.2 
pmol/g of tissue) remaining after removal of 
various specific regions. 
In contrast to the pronounced differences in 
LTG production, the capacity to produce LTB4 
exhibited much less variation (fig.2). The highest 
level of LTB4 was found in the hypothalamus 
(125.1& 5.3 pmol/g of tissue) and the lowest in 
cerebellum (52.8 k6.1 pmol/g of tissue). Thus, 
there was only a two-fold difference in LTB4 pro- 
ducing capacity. The ratio of LTG to LTB4 levels 
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Fig. 1. RP-HPLC chromatograms of leukotrienes and 
HETEs formed in the hypothalamus. The hypothalamus 
(0.5 g of wet wt) was preincubated at 37°C for 10 min 
and incubated with ionophore A23187 (10pM) at 37°C 
for 30 min. The material was purified as described in the 
text. The arrows indicate the elution of known standard 
compounds. (a) Sample obtained after Sep-Pak Cl8 
chromatography of the upper phase of Folch’s 
extraction was subjected to RP-HPLC with solvent A. 
(b) 80% of the sample obtained after Sep-Pak Cl8 
chromatography of the lower phase of Folch’s 
extraction was subjected to RP-HPLC with solvent A. 
(c) 20% of the same sample was subjected to RP-HPLC 
with solvent B. 
were about 0.4 in cerebellum, 0.6 in the cortex, 0.8 
in the caudate and hippocampus, 1 .l in the 
medulla oblongata, 1.4 in the thalamus and 2.0 in 
the hypothalamus. No leukotriene formation 
could be detected in the absence of ionophore 
A23187. 
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Fig.2. Regional distribution of leukotriene synthesis in 
the rat brain. The experiments were performed as 
described in fig. 1. Blank values were obtained after 
incubation of the residual tissue in the absence of 
ionophore A23187. The results are mean values f 
ranges for two independent experiments. 
Fig.3 shows the production of HETEs by 
various regions of the rat brain. Significant 
amounts of 5-HETE, 9-HETE, ll-HETE, 
1ZHETE and 15HETE were detected in all 
regions tested. 9- and ll-HETE were identified as 
described [14]. However, the relative activity of 
various lipoxygenases differed depending on the 
region. Thus, 5-HETE was the major product in 
the hypothalamus, while ll-HETE and 1ZHETE 
were major products in the hippocampus and 
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Fig.3. The regional distribution of HETE synthesis in 
the rat brain. The experimental conditions were 
described in fig.1. Blank values were obtained as in 
fig.2. The results are means f ranges for two 
independent experiments. 
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medulla oblongata, respectively. The production 
of HETEs was independent of ionophore A23187 
stimulation, since the compounds were also 
detected in similar amounts in control incubations 
without the ionophore. 
4. DISCUSSION 
The regional distribution in the rat brain of the 
capacity to produce leukotrienes and HETEs after 
in vitro stimulation with ionophore A23187 was 
studied. Identification and quantitative analysis 
were performed using HPLC combined with com- 
puterized on-line UV-spectroscopy. 
The highest production of LTG was observed in 
the hypothalamus. The magnitude of LTC4 pro- 
duction in the regions was as follows; 
hypothalamus> thalamus> caudate nucleus> me- 
dulla oblongata = hippocampus> cortex) cerebel- 
lum, with about 12 times higher production in the 
hypothalamus as compared to the cerebellum. The 
results are in agreement with our previous observa- 
tions based on radioimmunoassay technique [3.] 
High LTC4 synthesis was observed in the residual 
tissue indicating a high capacity of LTC4 produc- 
tion also in other regions than those tested. 
Preliminary results using tissue from mesencepha- 
lon indicate a high LTG-producing capacity in this 
region (Miyamoto, T. et al., unpublished observa- 
tion).The finding that the hypothalamus has the 
highest capacity to produce LTG is of interest 
since LTC4 may have an important role as 
modulator of LH and LHRH secretion [l 1,121. 
The activity of LTB4 synthesis eem to be more 
uniformly distributed within the rat brain. 
Although we observed the highest level of LTB4 
production in the hypothalamus and lowest level in 
the cerebellum, the capacity to produce LTB4 did 
not differ more than 2-fold within all regions 
tested. The relative ratio of LTB4 to LTC4 pro- 
duction was considerably higher in the cerebellum 
as compared to hypothalamus and thalamus. 
Thus, LTB4 was the main leukotriene formed in 
cerebellum, while leukotriene synthesis in the 
hypothalamus was directed mainly towards LTC4 
formation. The results may suggest he importance 
of LTB4 for central nervous functions in regions 
such as the cerebellum and cortex. An alternative 
explanation may be that different cell types are 
responsible for the formation of LTG and LTB4 
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and that LTB4 is produced by more evenly 
distributed cells e.g. glial cells and/or endothelial 
cells from the microvasculature. 
We also demonstrate regional differences in the 
various lipoxygenases forming 5-HETE, 9-HETE, 
1 l-HETE, 12-HETE and 15HETE, although 
these products were widely distributed in all 
regions tested. In agreement with the high 
leukotriene production in the hypothalamus, 
5-HETE was the main monohydroxyeicosatetra- 
enoic acid formed in this region indicating that 
arachidonic acid metabolism in hypothalamus is’ 
directed against production of 5lipoxygenase 
products. We recently suggested that ll-HETE 
was mainly formed as a by-product in the cyclo- 
oxygenase catalyzed reaction since it was inhibited 
by indomethacin, a specific cycle-oxygenase in- 
hibitor [ 141. Surprisingly, HETEs were produced 
without the stimulation of ionophore A23187, in- 
dicating that mechanical stimulation of the tissue 
activates the various lipoxygenases in the brain 
Il41. 
In summary, we demonstrate that LTG syn- 
thesis was prominent in the hypothalamus. A con- 
siderable formation of LTC4 was also observed in 
the thalamus, while the production capacity was 
low in the brain cortex and cerebellum. The activi- 
ty of LTB4 synthesis was more equally distributed 
in the rat brain. In addition, we demonstrate that 
the rat brain contains various lipoxygenase ac- 
tivities which are widely distributed. The present 
finding of the highest LT&producing capacity in 
the hypothalamus may provide further evidence 
for a role of this leukotriene in neuroendocrine 
function. However, since leukotrienes and 
monohydroxyeicosatetraenoic a ids are also form- 
ed in other parts of the brain, lipoxygenase 
products may have additional roles in the central 
nervous system. Such potential roles have to be 
further elucidated. 
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